- Trials with a EudraCT protocol (1,699)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,699 result(s) found for: Point of care.
Displaying page 9 of 85.
EudraCT Number: 2015-001401-13 | Sponsor Protocol Number: RRK5174 | Start Date*: 2016-04-07 | |||||||||||
Sponsor Name:University Hospitals Birmingham NHS Foundation Trust | |||||||||||||
Full Title: A Multi-Centre Randomised Controlled Trial of Pre-Hospital Blood Product Administration versus Standard Care for Traumatic Haemorrhage | |||||||||||||
Medical condition: Hypotension after trauma, due to haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003596-36 | Sponsor Protocol Number: RAPID-1DFU[2018/08] | Start Date*: 2018-11-30 | |||||||||||
Sponsor Name:Biotherapy Services Ltd. | |||||||||||||
Full Title: A single centre, open label Randomised Controlled Trial of the RAPID™* PRP (Platelet Rich Plasma) Haematogel Wound Care Treatment in addition to Usual and Customary Care, (UCC); compared to Usual a... | |||||||||||||
Medical condition: The treatment of chronic diabetic foot ulcers of longer than 12weeks duration. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001201-10 | Sponsor Protocol Number: FEN-PPA-401 | Start Date*: 2004-07-26 | |||||||||||
Sponsor Name:JANSSEN-CILAG | |||||||||||||
Full Title: Comparison of transdermal fentanyl PCA and IV morphine PCA in the management of post-operative pain control. | |||||||||||||
Medical condition: Treatment of moderate to severe post-operative pain in subjects who have undergone an elective major abdominal or orthopaedic surgical procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004706-25 | Sponsor Protocol Number: V1290413 | Start Date*: 2014-04-02 |
Sponsor Name:University of Edinburgh (ACCORD) [...] | ||
Full Title: A Feasibility study looking at the use of Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS | ||
Medical condition: Gestational Diabetes Mellitus (GDM) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005971-18 | Sponsor Protocol Number: 13-617 | Start Date*: 2014-01-24 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: TimeToStop (TTS) Trial, A randomised controlled trial of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery | ||
Medical condition: We will investigate possible cognitive benifits of early antiepileptic drug withdrawal after pediatric epilepsy surgery. The concerning medical condition is refractory epilepsy | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005004-21 | Sponsor Protocol Number: THOR-TUE-01 | Start Date*: 2015-12-23 | |||||||||||
Sponsor Name:Universitätsklinikum Tübingen, STZ eyetrial am Department für Augenheilkunde | |||||||||||||
Full Title: THOR - Tübingen Choroideremia gene therapy trial open label Phase 2 clinical trial using an adeno-associated viral vector (AAV2) encoding Rab-escort protein 1 (REP1) | |||||||||||||
Medical condition: Choroideremia (CHM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004872-17 | Sponsor Protocol Number: IC2020-04 | Start Date*: 2021-03-18 | ||||||||||||||||
Sponsor Name:INSTITUT CURIE | ||||||||||||||||||
Full Title: A Double-blind Randomized non-inferiority Trial of erector spinae block (ESP) versus paravertebral block (PVB) before Breast Cancer Surgery: Effects on acute Postoperative Pain | ||||||||||||||||||
Medical condition: Nervous Block erector spinae plane (ESP) or paravertebral block (PVB) preoperatively in women with breast adenocarcinoma without metastasis or breast in situ adenocarcinoma to by treated either by... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005130-15 | Sponsor Protocol Number: 2019/ABM/01/00009 | Start Date*: 2021-09-30 | |||||||||||
Sponsor Name:Nicolaus Copernicus University in Torun | |||||||||||||
Full Title: Evaluation of safety and efficacy of two ticagrelor-based de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicentre, double-blind ELECTRA RCT study. | |||||||||||||
Medical condition: Acute Coronary Syndrom (ACS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021069-63 | Sponsor Protocol Number: BCB109(H8O-MC-GWDQ) | Start Date*: 2011-06-23 | |||||||||||
Sponsor Name:Amylin Pharmaceuticals, LLC | |||||||||||||
Full Title: A randomized, placebo, controlled clinical trial to evaluate cardiovascular outcomes after treatment with Exenatide Once Weekly in patients with type 2 diabetes mellitus | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) LV (Completed) AT (Completed) GB (Completed) CZ (Completed) SK (Completed) HU (Completed) BG (Completed) IT (Completed) BE (Completed) NL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000830-12 | Sponsor Protocol Number: E5501-G000-302 | Start Date*: 2012-08-28 | ||||||||||||||||||||||||||
Sponsor Name:Eisai Limited | ||||||||||||||||||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Plus Standard of Care... | ||||||||||||||||||||||||||||
Medical condition: Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Completed) SK (Completed) BE (Completed) CZ (Completed) PL (Completed) BG (Completed) GR (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020360-38 | Sponsor Protocol Number: CV181-058 | Start Date*: 2011-10-31 | |||||||||||
Sponsor Name:Bristol Myers Squibb International Corporation | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patien... | |||||||||||||
Medical condition: diabetes type 2 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) Outside EU/EEA IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004152-22 | Sponsor Protocol Number: DEX-TRA-06 | Start Date*: 2016-03-01 | |||||||||||
Sponsor Name:MENARINI RICERCHE S.p.A. | |||||||||||||
Full Title: Analgesic efficacy of oral dexketoprofen trometamol/tramadol hydrochloride versus tramadol hydrochloride/paracetamol: a randomised, double-blind, placebo and active-controlled, parallel group study... | |||||||||||||
Medical condition: moderate to severe acute pain after removal of impacted lower third molar | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) ES (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003865-11 | Sponsor Protocol Number: NEOD001-CL002 | Start Date*: 2015-11-27 | |||||||||||
Sponsor Name:Prothena Therapeutics Limited | |||||||||||||
Full Title: A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care vs. Placebo Plus Standard of Care in Subjects with Light Chai... | |||||||||||||
Medical condition: Light chain (AL) amyloidosis involves a hematologic disorder caused by clonal plasma cells that produce misfolded immunoglobulin light chains. Overproduction of misfolded light chains results in bo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended) ES (Completed) BE (Prematurely Ended) NL (Prematurely Ended) FR (Prematurely Ended) GB (Prematurely Ended) GR (Completed) PL (Prematurely Ended) DK (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014913-28 | Sponsor Protocol Number: 09_056R | Start Date*: 2011-02-03 |
Sponsor Name:London School of Hygiene & Tropical Medicine | ||
Full Title: RETRO-PRO: The effectiveness of simvastatin compared to atorvastatin: an e-clinical randomised trial within a research database in routine clinical practice - a feasibility study | ||
Medical condition: subjects who in the opinion of the GP investigator would require a statin for primary prevention according to the 2008 NICE guideline on lipid modification: adults over 40 who have a 20% or greater... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002316-27 | Sponsor Protocol Number: 1239/2013 | Start Date*: 2013-08-27 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Hemodynamic effects of stored blood transfusion in intensive care patients | |||||||||||||
Medical condition: Anemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004797-33 | Sponsor Protocol Number: Obstetrics1.0 | Start Date*: 2018-06-13 |
Sponsor Name:CHU Tivoli | ||
Full Title: The efficacy of continuous ropivacaine wound infusion after cesarean delivery in pain management. | ||
Medical condition: Poor postoperative pain control leads to decreased satisfaction with care, prolonged recovery time and increased use of health care resources. Despite their efficacy, opioids are associated with na... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003557-15 | Sponsor Protocol Number: HMB-ICU | Start Date*: 2018-08-31 | |||||||||||
Sponsor Name:Guy's and St Thomas NHS Foundation Trust | |||||||||||||
Full Title: A Study to Investigate the Effect of β-Hydroxy-β-Methylbutyrate (HMB) on Skeletal Muscle Wasting in Early Critical Illness. | |||||||||||||
Medical condition: Critical illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010366-28 | Sponsor Protocol Number: 69/09 | Start Date*: 2009-06-13 | |||||||||||||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||||||||||||
Full Title: Effects of different doses of remifentanil in patients ventilated in Pressure Support Ventilation (PSV) vs Neurally Adjusted Ventilatory Assist (NAVA) | |||||||||||||||||||||||
Medical condition: Acute Respiratory Failure (ARF) or with a difficult weaning in patients ventilated | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001777-71 | Sponsor Protocol Number: RAVEN | Start Date*: 2020-05-06 | ||||||||||||||||
Sponsor Name:Guy’s and St Thomas' NHS Foundation Trust | ||||||||||||||||||
Full Title: Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts - RAVEN | ||||||||||||||||||
Medical condition: Severe COVID-19 infection with risk of need for mechanical ventilation. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003158-15 | Sponsor Protocol Number: GA1406 | Start Date*: 2014-10-10 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
Full Title: A randomised, assessor blind, placebo controlled exploratory study in healthy volunteers, to characterise the acid neutralisation activity of sodium alginate oral suspension in the fasted state, us... | ||
Medical condition: To pilot the use of a custom designed pH catheter for the measurement of intragastric pH to characterise the antacid action of Gaviscon Double Action versus placebo. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
